These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1100 related articles for article (PubMed ID: 6499732)

  • 21. Lectin-dependent cell-mediated cytotoxicity: assessment of cytotoxic reactivity following challenge with syngeneic tumors.
    Laux DC; Parker BM; DiSciullo SO; Petrarca MA; McAllister CG
    J Natl Cancer Inst; 1984 Mar; 72(3):667-72. PubMed ID: 6583449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of cytotoxic factor in the spleen of dengue virus-infected mice.
    Chaturvedi UC; Bhargava A; Mathur A
    Immunology; 1980 Aug; 40(4):665-71. PubMed ID: 6968713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16].
    Gankovskaia LV; Pyl'nova TI; Sokolova EV; Koval'chuk LV
    Biull Eksp Biol Med; 1980 Sep; 90(9):346-8. PubMed ID: 7000202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
    Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes.
    Chapoval AI; Nelson H; Thibault C
    J Immunol; 1995 Aug; 155(3):1296-303. PubMed ID: 7636196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
    Bonardelle D; Benihoud K; Kiger N; Bobé P
    J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T; Harada M; Tamada K; Abe K; Nomoto K
    Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
    Olsson L; Kiger N; Kronstrom H
    Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antitumor effect of gene gun-mediated DNA vaccine pWRG-neu immunization in C57BL/6 mice].
    Zha YY; Lin C; Zhang SR; Liang X; Zhang XY; Fu M; Zhang ZQ; Wu M
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):320-4. PubMed ID: 12921556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccines.
    Ribas A; Amarnani SN; Buga GM; Butterfield LH; Dissette VB; McBride WH; Glaspy JA; Ignarro LJ; Economou JS
    Cancer Gene Ther; 2002 Nov; 9(11):875-83. PubMed ID: 12386826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study on the complement-dependent cytotoxic effect of the sera of hamsters bearing transplanted melanoma.
    Kozłowska K; Zurawska-Czupa B; Kostulak A
    Arch Immunol Ther Exp (Warsz); 1985; 33(3):435-42. PubMed ID: 4062508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of phytohemagglutinin on the cytotoxic activity of lymphocytes].
    Artsimovich NG; Shalyminova IuA; Fadeeva TA; Zakharova TE
    Dokl Akad Nauk SSSR; 1980; 253(3):751-2. PubMed ID: 7428599
    [No Abstract]   [Full Text] [Related]  

  • 35. Further evidence of immunomodulatory effects of cimetidine.
    Strejcek J; Suhajová E; Jíra M; Písa P
    Allerg Immunol (Leipz); 1984; 30(2):117-22. PubMed ID: 6237557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoregulatory factors derived from human tumors. I. Immunologic and biochemical characterization of factors that suppress lymphocyte proliferative and cytotoxic responses in vitro.
    Roth JA; Grimm EA; Gupta RK; Ames RS
    J Immunol; 1982 May; 128(5):1955-62. PubMed ID: 6460814
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune response to a transplantable malignant melanoma in mice.
    Bartholomaeus WN; Bray AE; Papadimitriou JM; Keast D
    J Natl Cancer Inst; 1974 Oct; 53(4):1065-72. PubMed ID: 4547798
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in host immunity following excision of a murine melanoma.
    Bray AE; Keast D
    Br J Cancer; 1975 Feb; 31(2):170-5. PubMed ID: 1164467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of human interferon on lectin-dependent cellular cytotoxicity.
    Einhorn S; Blomgren H
    J Clin Lab Immunol; 1981 Jan; 5(1):31-6. PubMed ID: 6163854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of lymphocytes on the growth of transplanted adenocarcinoma of the colon in mice].
    Dontsov VI
    Eksp Onkol; 1989; 11(5):48-51. PubMed ID: 2791956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.